Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2
Different homologous and heterologous vaccination regimens have been used for COVID-19. Here the authors show in a cohort analysis from Catalonia that heterologous vaccination with ChAdOx1 followed by BNT162b2 has better vaccine effectiveness than two doses of ChAdOx1.
Bibliographic Details
Main Authors: |
Eduardo Hermosilla,
Ermengol Coma,
Junqing Xie,
Shuo Feng,
Carmen Cabezas,
Leonardo Méndez-Boo,
Francesc Fina,
Elisabet Ballo,
Montserrat Martínez,
Manuel Medina-Peralta,
Josep Maria Argimon,
Daniel Prieto-Alhambra |
Format: | Article
|
Language: | English |
Published: |
Nature Portfolio
2022-03-01
|
Series: | Nature Communications
|
Online Access: | https://doi.org/10.1038/s41467-022-29301-9
|